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Abstract : The objective of the study was to investigate the hypoglycaemic properties of Malaysian cocoa 
(Theobroma cacao) polyphenols extract in-vivo and insulin sensitivity in-vitro. Cocoa extract (CE) (containing 
190 - 286 mg total polyphenol per gram extract) was prepared from fermented and roasted (140°C, 20 min) 
beans by extracting with 80% ethanol in the ratio of 1 to 10. For the in-vivo study, the CE was administered 
in three dosages (1%, 2%, and 3%) to groups of normal and diabetic rats for a period of 4 weeks by force-
feeding. Results showed that dosages of 1% and 3% CE significantly reduced (p < 0.05) plasma glucose levels 
in the diabetic rats. An in-vitro study (BRIN-BD11 cell lines) was used to evaluate the effect of CE on insulin 
sensitivity. The results demonstrated that CE at a concentration of 0.1 mg/ml significantly increased (p < 
0.05) insulin level compared to the control. The results of this study showed that Malaysian cocoa polyphenol 
extract have the potential of being an insulin-mimetic agent. Further studies are on-going to elucidate the 
underlying mechanisms of polyphenols present in CE that contribute to the reduction of plasma glucose 
levels and insulin mimicking activity. 
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IntroduCtIon
Diabetes mellitus is a non-communicable disease, 
which is considered one of the five leading causes 
of death in the world today. Recently, the search 
for appropriate hypoglycaemic agents has focused 
on plants used in traditional medicine, partly 
because of leads provided by traditional medicine 
to natural products with potentials of being better 
treatments compared to currently used drugs 
(Lu et al., 2002; Kar et al., 2003; Jang et al., 2003). 
Drugs such as sulphonylureas, lead to higher risk 
of hypoglycaemia, and metformin brings a higher 
risk of lactic acidosis.  Due to the side effects of 
these drugs, many studies have been conducted to 
explore natural products derived from plants which 
have potential hypoglycaemic effects (Kamtchouing 
et al., 1998; Jayakar and Suresh, 2003; Ladeji et al., 
2003; Maghrani et al., 2003).
 Besides traditional medicinal plants, cocoa 
beans were thought to have fearsome magical 
powers by the Mayas and were carefully used in 
rituals, religious ceremonies and healings by priests. 
The Mayas used cocoa medicinally as a treatment 
for fever, coughs and even to help ease discomfort 
during pregnancy. After the 16th century conquest 
of Central America by Spain, Cortes introduced 
cocoa to Europe, where it was typically viewed as 
a healthy and nutritious beverage (Dillinger et 
al., 2000). Cocoa beans were recently recognized 
as a rich source of polyphenols, specifically 
procyanidins. Zumbe (1998) reported that total 
polyphenol content of the cocoa bean is about 
6-8% by weight of the dry bean. Some of the earliest 
studies on procyanidins also established that the 
major flavanoids of cocoa bean are catechin, 
epicatechin, the dimers [epicatechin-(4β®8)-
catechin (procyanidin B-l) and epicatechin-(4β®8)-
epicatechin (procyanidin B-2)] and the trimer 
[epicatechin-(4β®8)2 epicatechin (procyanidin 
C-l)] (Porter et al., 1991; Osakabe et al., 1998). Upon 
fermentation and roasting, these procyanidins 
are converted to the largely insoluble red-brown 
material (tannin) resulting in the characteristic 
colour and taste of chocolate (Pettipher, 1986).
Polyphenols have been a choice of research interest 
for decades, mostly because of their antioxidant 
properties (Wiseman et al., 1997; Sanbogi et al., 1998; 
Netzel et al., 2003). The consumption of flavanoids, 
including those found in cocoa and other cocoa 
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products have been associated with reduction 
in the risk of heart diseases, having potentially 
beneficial effects on inflammatory activity, and 
being cancer-protective agents (Borchers et al., 
2000). Recent research showed the ability of cocoa 
to reduce platelet activation in vivo, which can 
cause atherosclerosis (Rein et al., 2000). Oxidative 
stress is well known to be an important factor 
leading to chronic disease such as diabetes mellitus 
and atherosclerosis. Sabu et al. (2002) reported 
that administration of green tea polyphenols was 
found to reduce oxidative stress and serum glucose 
tolerance in alloxan-diabetic rats. A similar finding 
was reported by Ceriello et al. (2001) for red wine 
in humans. Our previous study on oral glucose 
tolerance test (OGTT) of diabetic rats showed that 
cocoa powder extract could reduce blood glucose 
levels (Amin et al., 2004). However, limited studies 
have been done on the hypoglycaemic effect of 
polyphenol-rich cocoa extract. Therefore, this 
study was designed to assess the effectiveness 
of polyphenol-rich cocoa extract in reducing 
hyperglycaemia based on in-vivo (animal) and in-
vitro studies.
MAterIAls And MetHods 
Preparation of extract from cocoa beans
Fermented and dried Malaysian cocoa beans 
were purchased from KL-Kepong Cocoa Products 
Sdn. Bhd., Port Klang, Selangor, Malaysia. The 
beans were roasted using an air-oven for 20 min 
at 140ºC (Jinap et al., 1998). After cooling to room 
temperature, the beans were deshelled using a 
cocoa breaker (Limprimita, John Gordon and Co., 
UK). The broken nibs were ground, then defatted 
with petroleum-ether (b.p 40-60ºC) using a Soxhlet 
apparatus in order to remove cocoa butter. The 
defatted sample was air-dried to remove solvent 
residues. The extract was prepared by extracting the 
defatted powder with 80% (v/v) ethanol for 2 hr. 
The ethanol residue was removed from the extract 
using a rotary evaporator (Buchi Rotavor R-200, 
Switzerland) under reduced pressure for 20 min at 
70ºC and the sample was then lyophilised.
Determination of total phenolic content
The total phenolic content was determined 
according to the Folin-Ciocalteu method  (Velioglu 
et al., 1998). Briefly, the cocoa extract was dissolved 
in 80% (v/v) ethanol and then centrifuged (Rotofix 
32, Hettich Zentrifugen, Germany) at 1000 x g for 15 
min. A total of 100 µl of the supernatant was mixed 
with 0.75 ml of Folin-Ciocalteu reagent (previously 
diluted 10-fold with distilled water) and allowed to 
stand at room temperature for 5 min. Then, 0.75 
ml of sodium carbonate (60 g/l) solution was added 
to the mixture. This was allowed to stand at room 
temperature for 90 min and the absorbance was 
read at 725 nm using a UV-Vis spectrophotometer 
(Anthelie Advanced 5, Secomam, France). A 
standard calibration curve was obtained from 0.02 
- 0.12 mg/ml of (-)-epicatechin (Sigma Co., St. 
Louis, USA). Results were expressed as epicatechin 
equivalents in milligrams per gram extract. 
Animal study
Ninety male (n = 90) Sprague-Dawley rats were 
purchased from Syarikat Usaha Cahaya Sdn. Bhd., 
Batu Caves, Selangor, Malaysia. This study was 
approved by the Animal Care and Use Committee 
of the Faculty of Medicine and Health Sciences, 
Universiti Putra Malaysia. The rats were housed in 
individual plastic cages with stainless steel covers 
and kept at room temperature (24-28°C) under 
12 h dark-light cycle. Rats were allowed free access 
to their respective diets and water. All rats were 
allowed 1 week to adapt to the environment before 
the treatments were administered. The experiment 
was carried out for 4 weeks, and body weights and 
blood glucose levels were recorded weekly.  The 
rats were divided into nine groups each consisting 
of ten rats as follows: 
Group 1: Normal rats  administered sal ine 
 solution
Group 2: Normal rats administered 1% CE
Group 3: Normal rats administered 2% CE
Group 4: Normal rats administered 3% CE
Group 5: Diabetic rats administered saline 
 solution
Group 6: Diabetic rats administered 1% CE
Group 7: Diabetic rats administered 2% CE
Group 8: Diabetic rats administered 3% CE
Group 9: Diabetic rats administered glybenclamide 
 (100 mg/ml in saline solution)
 The three dosages (1%, 2%, and 3%) of CE 
were selected based on our previous study (Ruzaidi 
et al., 2005). CE was suspended in 0.9% (w/v) saline 
solution, then administered daily (1 ml/ 100 g body 
weight) to the experimental rats by direct stomach 
intubation, using a force-feeding needle. The rats 
were administered with their respective treatments 
after induction with diabetes using streptozotocin 
(STZ). 
Induction of diabetes
Streptozotocin (STZ) (Sigma Co., St. Louis, USA) 
was used to induce diabetes. After overnight fasting, 
rats were injected intravenously with 45 mg/kg body 
weight of STZ dissolved in 0.05 M citrate buffer, 
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pH 4.5. Normal rats were injected with the same 
volume of 0.05 M citrate buffer. Three days after 
STZ injection, blood was collected from the tail 
milking using a Blood Glucose Sensor (MediSense 
Optium, Abbot Laboratories, USA) to ensure that 
the rats had diabetes. Only rats with fasting blood 
glucose of 15 mmol/l and above were included in 
this study.
Determination of plasma glucose levels
At 0 and 4 weeks of the experiment, 5 ml blood was 
collected from all rats through cardiac puncture 
and placed into a vacutainer tube. Then, the 
samples were centrifuged (Universal 32®, Hettich 
Zentrifugen, Germany) for 10 min at 1000 x g at 
room temperature. The supernatant was collected 
and kept at -20°C for determination of plasma 
glucose levels using a Chemistry Analyzer (Hitachi 
902 Automatic Analyzer, Japan).    
Measurement of insulin secretion
For measurement of insulin-release from cell 
monolayers, BRIN-BD11 cells were seeded into 
24-multiwell plates (Nunc, Roskilde, Denmark) at 
a density of 2.5 x 105 cells per well in RPMI-1640 
medium and allowed to attach during overnight 
incubation (37ºC; 5% CO2). After washing with PBS 
buffer, pre-incubations were performed using the 
Krebs-Ringer bicarbonate buffer pH 7.4 for 40 min 
(37ºC; 5% CO2). Then, the cells were incubated 
at 37ºC under 5% CO2 with KRB buffer (pH 7.4) 
supplemented with different concentrations of CE. 
Following 30 min of incubation, the aliquots were 
removed from each well, then centrifuged at 1000 x 
g for 1 min at room temperature (Centrifuge 5414, 
Eppendorf, Germany), and supernatants were kept 
at -20ºC before determination using the ELISA 
(Mercodia, Uppsala, Sweden).
Statistical analysis 
Data are expressed as means ± S.E.M. One-way 
ANOVA was used for statistical analysis. Duncan’s 
multiple range test was used to determine any 
significant differences between the means at 5% 
level of probability.
results
Normal and diabetic rats experiment were carried 
out separately which helps to explain why the 
initial body weight of normal and diabetic rats 
were significantly different. At the beginning of 
experiments, all groups consisted 10 rats. However, 
about half of the diabetic-induced rats died after 
STZ injection due to extreme hyperglycaemia.
 Table 1 shows the effect of CE on body weights 
in normal and diabetic rats. Body weights of all normal 
rats increased significantly (p < 0.05) at the end of 
the experiment (week 4). No significant differences 
in body-weight changes were observed among the 
groups of normal rats. On the other hand, there was 
significant reduction (p < 0.05) in body weight of 
DC, DCE1, DCE2 and DG groups in diabetic rats. 
The weight loss in DC, DCE1, DCE2 and DG groups 
at the end of the experiment was 31%, 17%, 24% 
and 20% compared to week 0, respectively. The loss 
in body weights were not significantly different in 
the DCE3 group compared to their initial weights. 
In addition, the mean body weight in the DCE3 
group was significantly higher (p < 0.05) compared 
to that of DC, DCE2 and DG groups.
Group n
Body weight (g)
week 0 week 4
Normal control (NC) 8 184.4 ± 5.7b 279.8 ± 8.0a
Normal + 1% CE (NCE1) 8 182.2 ± 6.2b 282.6 ± 7.3a
Normal + 2% CE (NCE2) 9 184.1 ± 7.3b 277.9 ± 12.0a
Normal + 3% CE (NCE3) 10 180.4 ± 7.5b 265.1 ± 12.0a
Diabetes control (DC) 6 256.4 ± 12.1a 176.4 ± 18.3b
Diabetes + 1% CE (DCE1) 4 254.5 ± 10.6a 212.5 ± 2.5b
Diabetes + 2%CE (DCE2) 5 249.0 ± 12.1a 189.0 ± 23.7b
Diabetes + 3% CE (DCE3) 5 254.7 ± 10.8a 241.8 ± 26.1a
Diabetes + Glibenclamide (DG) 4 248.6 ± 10.2a 197.8 ± 7.1b
Values were expressed as means ± S.E.M. Different letters in a column indicate significant differences (p < 0.05). Body weights were 
measured every day at 9.00 am
table 1: Effect of cocoa extract (ce) on body weight of rats
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 Initial plasma glucose level of normal rats 
was in the range of 3.1 - 8.2 mmol/l. The mean 
plasma glucose level was significantly increased 
(about 400%) in diabetic groups as compared to 
normal groups after 3 days STZ injection. In normal 
rats, no significant differences in glucose levels 
were observed between week 0 and 4 (Figure 1). 
For diabetic rats, plasma glucose levels decreased 
significantly (p < 0.05) after feeding with 1% and 
3% CE (DCE1 and DCE3) at the end of experiment 
(Figure 2). The reduction in percentage plasma 
glucose levels in DCE1 and DCE3 groups was 
about 47% and 57%, respectively at the end of 
experiment. Plasma glucose levels in DCE2 and DG 
groups tend to be lower compared to DC, but it was 
not significantly different.
 Figure 3 shows insulin secretion of BRIN-BD11 
rat pancreatic cell-lines at various concentrations 
of CE. In this study, five concentrations (2.0, 1.0, 
0.5, 0.1 and 0.05 mg/ml) of CE were used. The of 
0.1 mg/ml CE showed a significant increase (p < 
0.05) in insulin secretion compared to the control. 
BRIN-BD11 cells treated with 2.0 mg/ml CE was 
significantly lower (p < 0.05) compared to the 
control in insulin secretion.
 The results showed that a range from 
0.05–0.1 mg/ml CE is capable of enhancing basal 
insulin secretion (at 2 mmol/l glucose) about 
9-15% compared to the untreated BRIN-BD11 
cell lines (control). However, insulin secretion at 
concentrations of 0.5, 1.0 and 2.0 mg/ml was lower 
compared to the control. 
dIsCussIon
Ver y limited published data is available on 
hypoglycaemic effect of cocoa products based on 
in-vitro or in-vivo studies. This study was initiated to 
investigate the effect of CE on glucose levels using 
in-vitro (cell culture) and in-vivo (animal models) 
methods. For diabetic models, STZ was used to 
induce diabetic conditions in rats. Elsner et al. 
(2000) suggested that STZ induces hyperglycaemia 
by damaging DNA in the nuclei of pancreatic β-cells 
through alkylation, leading to an increase in poly 
(ADP-ribose) synthase. The increase in this enzyme 
activity results in a drastic decrease in nicotinamide 
adenine dinucleotide (NAD) concentrations of 
the β-cells, then a decrease in the number of 
β-cells and death of the cells. All these changes 
may induce dysfunction of the pancreas in insulin 
secretion. According to Thulesen et al. (1997), STZ 
transported into β-cells through glucose transporter 
GLUT-2 located on their cell membranes, and this 
will injure the mitochondria. This will inevitably 
lead to a reduction of ATP generation through 
electron transport system and an increase in ADP 
concentrations. Subsequent degradation of ADP 
provides hypoxanthine, a substrate of xanthine 
oxidase (XOD). When XOD reaction takes place 
in β-cells, oxygen radicals which are free radicals 
will be produced, resulting in cell damage and the 
onset of the diabetic conditions.
Figure 1: Plasma glucose levels of normal rats fed with cocoa extract (CE). No significant differences between 
week 0 and 4 for all groups. NC: Normal control (n = 8); NCE1: Normal + 1% CE (n = 8); 
NCE2: Normal + 2% CE (n = 9); NCE3: Normal + 3% CE (n = 10)
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Figure 2: Plasma glucose levels of diabetic rats fed with cocoa extract (CE). Values with different superscripts were 
significantly different (p < 0.05). DC: Diabetes control (n =6); DCE1: Diabetes + 1% CE (n = 4); DCE2: 
Diabetes + 2% CE (n = 5); DCE3: Diabetes + 3% CE (n = 5); DG: Diabetes + glibenclamide (n = 4).
Figure 3: The effect of cocoa extract (CE) on in-vitro insulin secretion from BRIN-BD11 cell lines. The extract 
was prepared at concentrations of 0.05 to 2.0 mg/ml. Values are expressed as means ± S.E.M. of four 
replicate determinations. Values with different superscripts were significantly different (p < 0.05)
 In this study, rats were administered orally 
(force-feeding) with their respective treatments 
daily. The results revealed that all normal rats 
showed an increase in body weights. It could be 
suggested that CE did not affect the growth of 
normal rats. In diabetic rats, a general decrease 
in body weight was observed after the injection of 
STZ. In the DCE3 group, however, no significant 
decrease was observed, suggesting that CE could 
normalize the weight loss caused by STZ. This study 
clearly demonstrated that oral administration of 
1% and 3% CE exhibited a significant decrease (p 
< 0.05) in plasma glucose levels in STZ-induced 
diabetic rats compared to the control groups.
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 Hypoglycaemic effects of some plants have 
been reported due to polyphenols (Maghrani et al., 
2003; Sachdewa and Khemani, 2003). Since cocoa 
beans is well known to be rich in polyphenols, it 
is possible that the hypoglycaemic effect could 
be related to these components. Polyphenols are 
reported to be the potential bioactive component 
for hypoglycaemic properties (Ivora et al., 1989; 
Manickan et al., 1997). These components were 
reported to demonstrate marked antioxidant 
activity. A significant reduction of plasma glucose 
levels in the group treated with CE may be due to 
the antioxidant properties of the CE. Antioxidant 
compounds are well known to possess free radical 
scavenging activity. Thus, it is suggested that 
glucose-lowering activity by CE could be due to 
polyphenols that inhibit or suppress the generation 
of free radical by STZ in diabetic rats. In addition, 
flavanoids have also been reported to regenerate 
damaged β-cells in alloxan diabetic rats (Chakravarty 
et al., 1982). Therefore, it is postulated that CE 
could also regenerate or rejuvenate the damaged 
of β-cells cause by STZ.
 Based on previous studies on hypoglycaemic 
effect of plants and herbs, several mechanisms of 
lowering blood glucose were proposed. One such 
mechanism of blood glucose lowering activity 
may be due to stimulation of peripheral glucose 
utilisation, especially in muscle and adipose tissue. 
Several medicinal plants have been reported to 
restore activity of key enzymes of glucose and 
glycogen metabolism which are strongly disturbed 
in STZ diabetic rats (Ugochukwu and Babady, 2003). 
Several studies on plants and herbs compounds 
have revealed that these compounds possess 
properties that mimick insulin action, preferably 
by interacting with the glycoprotein residues of the 
insulin receptor and enhanced glucose uptake by 
cells (Gray and Flatt, 1999) which is called insulin-
like activity. 
 Insulin is essential for maintaining glucose 
homeostasis and regulating carbohydrate, lipid, and 
protein metabolism (Saltiel and Kahn, 2001). After a 
meal, blood glucose levels increase and insulin plays 
a major role in keeping blood glucose levels within 
a narrow range. The β-cells of the pancreas respond 
to increasing glucose levels by releasing insulin 
into the blood. Insulin affects glucose turnover in 
many tissues. In liver, insulin inhibits glycogenolysis 
and gluconeogenesis (DeFronzo and Ferrannini, 
1987). In skeletal muscle, which accounts for 
approximately 75 % of insulin-mediated glucose 
disposal after a glucose challenge (DeFronzo et 
al., 1981; DeFronzo et al., 1985), insulin promotes 
glucose uptake into cells.
 It is strongly suggested that CE exhibited 
significant antihyperglycaemic activities in STZ-
induced rats. However, the mechanism of the 
hypoglycaemic effect of the CE is not clear. Although 
pancreatic regeneration after partial resection or 
pancreatic injury has been demonstrated in animal 
models, whether regeneration occurs or not in 
human pancreas is still controversial. Studies by 
Tsiotos et al. (1999) revealed that human pancreas 
does not regenerate after partial anatomical 
resection. Yanardag et al. (2003) reported that plant 
therapy cannot regenerate β-cells of the endocrine 
pancreas. Several published reports showed that 
antihyperglycaemic plants may affect circulating 
insulin levels (Esmaeili and Yazdanparast, 2004; 
Gray and Flatt, 1998). In the STZ-diabetic rat model, 
not all pancreatic ß-cells are destroyed, and the 
remaining cells can secrete a quantity of insulin 
sufficient to keep the animals alive for up to 2 
months (Ozcelikay et al., 1999). This study suggests 
that the mechanism of hypoglycaemic effect of CE 
could also be due to the surviving β-cells that are still 
able to release more insulin.
 Studies have shown that certain plants 
(�grimony eupatoria and Eucalyptus globules) could 
improve insulin secretion using BRIN-BD11 cell 
lines (Gray and Flatt, 1998). Based on the possibility 
that CE might stimulate the release of insulin from 
β-cells, BRIN-BD11 cell lines were used to evaluate 
the CE effect on insulin secretion. Incubations were 
performed with glucose-responsive BRIN-BD11 
cells (McClenaghan et al., 1996) to investigate the 
possible effects of CE on insulin secretion in vitro. 
The results showed that 0.1 mg/ml CE was able 
to stimulate insulin secretion in BRIN-BD11 cell 
lines. 
ConClusIon
This study indicated that CE could reduce high 
blood glucose levels in diabetic rats through 
enhancing insulin secretion in partially damaged 
pancreas. Determination of insulin levels in plasma 
of diabetic rats would be important to support the 
finding. The mechanisms of this pharmacological 
effect have yet to be determined.
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